Delivery Order SPE2DB20D3505-SPE2DB25FV0F9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,336.23 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat epilepsy and bipolar...
- The Defense Logistics Agency awarded a delivery order valued at $1,323.38 to AmerisourceBergen Drug Corp for Lamotrigine ER 200 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. Lamotrigine is a generic anticonvulsant and mood-stabilizing medication commonly used in military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count supply) valued at $3,688.24, with an award date of August 12, 2025, and ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count) with a ceiling value of $1,343.58 under a firm fixed-price contract type. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Lamotrigine ER 25 mg tablets in quantities of 30, with a ceiling value of $1,517.04. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,910.41 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 250 mg tablets (30-count packages). This contract, awarded on August 5, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $3,943.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count units), with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- This is a $1,065.82 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of 200 mg Lamotrigine ER tablets, which are used to treat certain types of seizures. The contract has a completion date of June 24, 2025 and is not set aside for any small business category. AmerisourceBergen Drug Corp is the prime...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $35,660 firm fixed price delivery order contract to provide 4562339082 Lamotrigine ER 25 MG tablets. As the prime contractor, Amerisourcebergen will deliver 30 count bottles of the generic anti-seizure medication to a Defense Department facility located in Conshohocken, Pennsylvania between September 28-29, 2023. The contract was awarded under the parent company Amerisourcebergen Corporation's Federal Supply Schedule...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lamotrigine ER 300 mg tablets in a quantity of 30 units, valued at $2,357.64. This delivery order represents a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV0F9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,824.31 to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used for seizure management and bipolar disorder treatment, reflecting the pharmaceutical distributor's role in supplying critical medications to military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 billion and extends through December 2026. This comprehensive pharmaceutical prime vendor vehicle enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. AmerisourceBergen's consistent performance on competitively awarded federal contracts across diverse therapeutic domains demonstrates its capability to fulfill essential medical supply requirements for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 7/22/25 |